Search research articles
Contact Us
Filters
Showing results (141-150 of 602) with videos related to
Page
of 61
Sort By:
The Journal of Biological Chemistry
|
February 15, 1987
Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein
M M Cornwell, I Pastan, M M Gottesman
Cancer Research
|
August 1, 1988
In situ hybridization analysis of acquisition and loss of the human multidrug-resistance gene
D W Shen, I Pastan, M M Gottesman
Journal of Bioenergetics and Biomembranes
|
August 1, 1990
Genetic basis of multidrug resistance of tumor cells
S E Kane, I Pastan, M M Gottesman
Nature Biotechnology
|
June 11, 2009
Structure of a multidrug transporter
Michael M Gottesman, Suresh V Ambudkar, Di Xia
Journal of the National Cancer Institute
|
February 26, 2013
The clinical relevance of cancer cell lines
Jean-Pierre Gillet, Sudhir Varma, Michael M Gottesman
Gene
|
September 30, 1993
Promoter resurrection by activators--a minireview
S Adhya, M Gottesman, S Garges, et al.
The Journal of Biological Chemistry
|
September 10, 1973
Studies on the mechanism of action of the gal repressor
S Nakanishi, S Adhya, M Gottesman, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
July 1, 1980
Ultrastructural localization to 10 nm filaments of an insoluble 58K protein in cultured fibroblasts
F Cabral, M C Willingham, M M Gottesman
Advances in Pharmacology (San Diego, Calif.)
|
May 20, 1999
Therapeutic strategies involving the multidrug resistance phenotype: the MDR1 gene as target, chemoprotectant, and selectable marker in gene therapy
J M Aran, I Pastan, M M Gottesman
Critical Reviews in Oncology/Hematology
|
January 1, 1992
Multidrug resistance in human cancer
L J Goldstein, I Pastan, M M Gottesman
Page
of 61
Search research articles
Search
Showing results (141-150 of 602) with videos related to
Sort By:
Page
of 61
The Journal of Biological Chemistry
|
February 15, 1987
Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein
M M Cornwell, I Pastan, M M Gottesman
Cancer Research
|
August 1, 1988
In situ hybridization analysis of acquisition and loss of the human multidrug-resistance gene
D W Shen, I Pastan, M M Gottesman
Journal of Bioenergetics and Biomembranes
|
August 1, 1990
Genetic basis of multidrug resistance of tumor cells
S E Kane, I Pastan, M M Gottesman
Nature Biotechnology
|
June 11, 2009
Structure of a multidrug transporter
Michael M Gottesman, Suresh V Ambudkar, Di Xia
Journal of the National Cancer Institute
|
February 26, 2013
The clinical relevance of cancer cell lines
Jean-Pierre Gillet, Sudhir Varma, Michael M Gottesman
Gene
|
September 30, 1993
Promoter resurrection by activators--a minireview
S Adhya, M Gottesman, S Garges, et al.
The Journal of Biological Chemistry
|
September 10, 1973
Studies on the mechanism of action of the gal repressor
S Nakanishi, S Adhya, M Gottesman, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
July 1, 1980
Ultrastructural localization to 10 nm filaments of an insoluble 58K protein in cultured fibroblasts
F Cabral, M C Willingham, M M Gottesman
Advances in Pharmacology (San Diego, Calif.)
|
May 20, 1999
Therapeutic strategies involving the multidrug resistance phenotype: the MDR1 gene as target, chemoprotectant, and selectable marker in gene therapy
J M Aran, I Pastan, M M Gottesman
Critical Reviews in Oncology/Hematology
|
January 1, 1992
Multidrug resistance in human cancer
L J Goldstein, I Pastan, M M Gottesman
Page
of 61